215 related articles for article (PubMed ID: 23635730)
1. Complications and continuation of intrauterine device use among commercially insured teenagers.
Berenson AB; Tan A; Hirth JM; Wilkinson GS
Obstet Gynecol; 2013 May; 121(5):951-958. PubMed ID: 23635730
[TBL] [Abstract][Full Text] [Related]
2. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices.
Aoun J; Dines VA; Stovall DW; Mete M; Nelson CB; Gomez-Lobo V
Obstet Gynecol; 2014 Mar; 123(3):585-592. PubMed ID: 24499755
[TBL] [Abstract][Full Text] [Related]
3. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A
Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933
[TBL] [Abstract][Full Text] [Related]
4. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
6. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
7. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
8. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study.
Bachofner M; Blickenstorfer K; Hutmacher J; Wehrle L; Leeners B; Merki-Feld G
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):407-414. PubMed ID: 30628516
[TBL] [Abstract][Full Text] [Related]
10. Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
Spotnitz ME; Natarajan K; Ryan PB; Westhoff CL
Obstet Gynecol; 2020 Feb; 135(2):319-327. PubMed ID: 31923062
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
13. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
16. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
[TBL] [Abstract][Full Text] [Related]
17. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
Sanders JN; Turok DK; Gawron LM; Law A; Wen L; Lynen R
Am J Obstet Gynecol; 2017 Jun; 216(6):590.e1-590.e8. PubMed ID: 28188772
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
19. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
20. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
Hinz EK; Murthy A; Wang B; Ryan N; Ades V
Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
